Next Article in Journal / Special Issue
Innate Immunity and Inflammation Post-Stroke: An α7-Nicotinic Agonist Perspective
Previous Article in Journal
Reduced Dendritic Cells Expressing CD200R1 in Children with Inflammatory Bowel Disease: Correlation with Th17 and Regulatory T Cells
Previous Article in Special Issue
Characterization of Peripheral Immune Cell Subsets in Patients with Acute and Chronic Cerebrovascular Disease: A Case-Control Study
Article Menu
Issue 12 (December) cover image

Export Article

Open AccessReview
Int. J. Mol. Sci. 2015, 16(12), 29011-29028;

The Role of the Neuroprotective Factor Npas4 in Cerebral Ischemia

School of Biological Sciences, The University of Adelaide, Adelaide, SA 5005, Australia
School of Medicine, The University of Adelaide, Adelaide, SA 5005, Australia
South Australian Health & Medical Research Institute, North Terrace, Adelaide, SA 5005, Australia
Author to whom correspondence should be addressed.
Academic Editor: Chris Sobey
Received: 31 August 2015 / Revised: 28 October 2015 / Accepted: 16 November 2015 / Published: 4 December 2015
(This article belongs to the Special Issue The Immune System and Inflammation in Cerebral Ischemia)
Full-Text   |   PDF [584 KB, uploaded 9 December 2015]   |  


Stroke is one of the leading causes of death and adult disability in the world. Although many molecules have been documented to have a neuroprotective effect, the majority of these molecules failed to improve the neurological outcomes for patients with brain ischemia. It has been proposed that neuroprotection alone may, in fact, not be adequate for improving the prognosis of ischemic stroke. Neuroprotectants that can regulate other processes which occur in the brain during ischemia could potentially be targets for the development of effective therapeutic interventions in stroke. Neuronal Per-Arnt-Sim domain protein 4 (Npas4) is an activity-dependent transcription factor whose expression is induced in various brain insults, including cerebral ischemia. It has been shown that Npas4 plays an important role in protecting neurons against many types of neurodegenerative insult. Recently, it was demonstrated that Npas4 indeed has a neuroprotective role in ischemic stroke and that Npas4 might be involved in modulating the cell death pathway and inflammatory response. In this review, we summarize the current knowledge of the roles that Npas4 may play in neuroinflammation and ischemia. Understanding how ischemic lesion size in stroke may be reduced through modulation of Npas4-dependent apoptotic and inflammatory pathways could lead to the development of new stroke therapies. View Full-Text
Keywords: apoptosis; ischemic stroke; neuroinflammation; neuroprotection; Npas4 apoptosis; ischemic stroke; neuroinflammation; neuroprotection; Npas4

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Choy, F.C.; Klarić, T.S.; Koblar, S.A.; Lewis, M.D. The Role of the Neuroprotective Factor Npas4 in Cerebral Ischemia. Int. J. Mol. Sci. 2015, 16, 29011-29028.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top